From GlobeNewswire: 2025-06-12 12:00:00

Shuttle Pharmaceuticals Holdings, Inc. will undergo a reverse stock split effective June 16, 2025, to comply with Nasdaq listing requirements. Every 25 shares will be combined into 1 share, reducing issued shares to around 1,048,401. The split also applies to stock from RSU grants and warrants. This move is part of Shuttle’s strategy to maintain compliance and strengthen its long-term capital structure. Shuttle Pharma focuses on developing therapies to enhance outcomes for cancer patients undergoing radiation therapy, aiming to improve cure rates and quality of life. Visit their website for more information: www.shuttlepharma.com.



Read more at GlobeNewswire: Shuttle Pharma Announces Reverse Stock Split will Become